Showing results (2571-2580 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|August 1, 2013
Current status of bevacizumab in advanced ovarian cancerFederica Tomao, Anselmo Papa, Luigi Rossi, et al.Oncotargets and Therapy|August 1, 2013
Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysisZhijun Yang, Chunyin Wei, Zhaoqing Luo, et al.Oncotargets and Therapy|July 10, 2013
Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcomaViviane Sonaglio, Ana C de Carvalho, Silvia R C Toledo, et al.Oncotargets and Therapy|July 10, 2013
Long term results of sentinel lymph node biopsy in early oral squamous cell carcinomaDidier Dequanter, Mohammad Shahla, Pascal Paulus, et al.Oncotargets and Therapy|July 23, 2013
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancerGordana Maric, April An Rose, Matthew G Annis, et al.Oncotargets and Therapy|August 1, 2015
Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinomaLinfeng Zheng, Sujuan Zheng, Xiaochun Yuan, et al.Oncotargets and Therapy|November 25, 2014
IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysisDaye Cheng, Yiwen Hao, Wenling ZhouOncotargets and Therapy|November 25, 2014
EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published dataYun Fan, Xiaoling Xu, Conghua XieOncotargets and Therapy|December 18, 2015
Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancerJun Qin, Jing Ke, Junfei Xu, et al.Oncotargets and Therapy|March 2, 2016
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE reviewSohyun Jeong, Jae Hyun Kim, Myeong Gyu Kim, et al.Pageof 674